EQHQ
Login
EQHQ
Search your stocks
Login
Command Palette
Search for a command to run...
Explore
Watchlists
Chat
Portfolio
Share
Profile
MEDIORG
Overview
Shareholding
Peers
Financials
Ratios
Concall
Feed
Documents
MEDIORG
Medicamen Organics Ltd.
35.7
(+0.00%)
1W: +4.39%
1M: -18.31%
1Y: +%
Financials
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Pros & Cons
POSITIVES
Consistent revenue growth with a strong performance in the latest quarter, reflecting robust demand in the manufacturing sector.
Improved profit margins indicating effective cost management and operational efficiency over the past quarters.
Increased investment in R&D leading to innovative product offerings, positioning the company well for future growth.
NEGATIVES
Declining net profit in the latest quarter compared to previous quarters, raising concerns about profitability sustainability.
Higher raw material costs impacting margins, which may affect pricing strategies moving forward.
Increased competition in the manufacturing sector, putting pressure on market share and growth potential.
Quarterly Results Data
Field
Trend
Expenses
-
Operating Profit
-
Other Income
-
Tax
-
Explore
Watchlists
Chat
Portfolio